美股A股
StockGist

Pacira BioSciences, Inc.

PCRXNASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United Sta…
$36.46-0.08%
报价 2026-11-13
市值
$1.46B
EV
$1.65B
PE (TTM)
103.2x
预期 PE (FY2026)
12.6x
52 周区间距高点 -0.1%
$19.16$36.49

筛选结果

pipeline · 2026-11-13
Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool

爆发潜力

2026-11-13
未命中✗ 收入线✗ EPS 线
财年收入倍数EPSPE
FY+22027-121.1x2.62 → 3.51(1.3x)10.4
FY+32028-121.2x2.62 → 4.58(1.7x)8.0

毛利率 79% · TTM 收入 $743M · 基数 EPS 2.62(调整后)

研究结论

还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。

去生成基本面报告 →

历史股价

加载中…

事件

0 条 · 随区间与图例筛选

该区间内无事件。

同行对比

FMP 同行列表 · 2026-05-16
公司市值今日预期营收增速毛利率PEEV/EBITDAP/FCF池
PCRXPacira BioSciences, Inc.$1.46B-0.1%+3.2%77%103.2x14.4x8.1x
KODKodiak Sciences Inc.$7.27B+2.7%+1783.3%0%–––
XNCRXencor, Inc.$2.78B-2.7%+45.7%93.9%–––
TNDMTandem Diabetes Care, Inc.$1.4B+14.6%+7.6%56.5%–––
ANABAnaptysBio, Inc.$1.38B-3.2%-32.8%99%–27.8x76.5x
URGNUroGen Pharma Ltd.$1.28B-0.8%+185.5%90.9%–––
CRONCronos Group Inc.$1.24B-0.9%+60.5%50.9%21.5x23.0x19.4x高增长
PHATPhathom Pharmaceuticals, Inc.$492.6M-2.7%+80.5%80.7%–––
OCSOculis Holding AG$471.6M+1.9%–-2,889.4%–––
同行中位数––+60.5%68.6%21.5x25.4x48.0x

研究全文

L2 基本面 memo

尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。

财务报表

Metric
2026-06-30
Q2 2026
2026-03-31
Q1 2026
2025-12-31
Q4 2025
2025-09-30
Q3 2025
2025-06-30
Q2 2025
2025-03-31
Q1 2025
2024-12-31
Q4 2024
2024-09-30
Q3 2024
Revenue$192.4M$177.4M$196.9M$179.5M$181.1M$168.9M$187.3M$168.6M
Gross Margin77%79.5%79.5%80.9%77.4%79.7%78.7%76.9%
Operating Margin2.2%2.6%1.6%3.5%4.7%1.2%13.2%-82.8%
Net Income$4.7M$2.9M$1.6M$5.4M$-4.8M$4.8M$16M$-143.5M
Diluted EPS0.120.070.040.12-0.110.10.34-3.11
Operating Cash Flow$57.5M$25.7M$43.7M$60.8M$12M$35.5M$33.1M$53.9M

研究材料

电话会纪要摘要
暂无纪要摘要。